Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic pain--challenge and response

K Budd1

  • 1Bradford Royal Infirmary, Yorkshire, England.

Drugs
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Tramadol effectively manages acute and chronic pain with potency similar to pethidine. Its favorable safety profile, including minimal respiratory depression and low dependence potential, makes it a valuable clinical option.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic analyses of the parasitic nematode, <i>Parelaphostrongylus tenuis</i>, in Missouri and Kentucky reveal unexpected levels of diversity and population differentiation.

Parasitology·2020
Same author

Old dog--new (ma)trix.

British journal of anaesthesia·2003
Same author

Oral low-dose glucocorticosteroids as compared with intravenous methylprednisolone pulses in the treatment of rheumatoid arthritis.

Rheumatology (Oxford, England)·1999
Same author

Tramadol revisited.

British journal of anaesthesia·1999
Same author

Controversies in palliative medicine.

British journal of hospital medicine·1999
Same author

Medical student attrition: a 10-year survey in one medical school.

Medical education·1996
Same journal

The Long Road to Long-Acting: What Oral PrEP and CAB-LA Teach Us About Scaling Lenacapavir.

Drugs·2026
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
Same journal

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

Drugs·2026
See all related articles

Area of Science:

  • Pharmacology
  • Pain Management
  • Clinical Therapeutics

Background:

  • Tramadol is an analgesic used for pain relief.
  • Its efficacy is comparable to pethidine.
  • It possesses an acceptable adverse event profile.

Purpose of the Study:

  • To evaluate the efficacy and safety of tramadol in pain management.
  • To compare tramadol's therapeutic benefits and adverse effects with existing analgesics.
  • To inform clinicians on the clinical utility of tramadol.

Main Methods:

  • Review of clinical studies on tramadol.
  • Analysis of tramadol's pharmacological properties.
  • Assessment of adverse event profiles and patient outcomes.

Related Experiment Videos

Main Results:

  • Tramadol demonstrates significant efficacy in treating both acute and chronic pain.
  • Common adverse events include nausea, vomiting, drowsiness, and dizziness.
  • Notably, tramadol exhibits minimal respiratory depression, low tolerance, and low dependence potential.

Conclusions:

  • Tramadol is a valuable agent for pain management due to its efficacy and favorable safety profile.
  • Its unique properties, such as lack of respiratory depression and low dependence risk, enhance its clinical appeal.
  • Clinicians can utilize this information to assess tramadol's suitability for individual patient needs.